drugset / Trial / NCT06653023
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator initiated trial to assess the efficacy and safety of a GPC3-targeting CAR-T therapy (REVO-UWD-03) in the HCC and Lung Cancer. It also aims to explore the feasibility of using a novel universal CAR-T cell platform.
Timeline
- Start
- 2024-10-23
- Primary completion
- 2027-10-20
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REVO-UWD-03 | Cell therapy | — | Other |
| Background | Mycophenolate Sodium | Unknown | 1440 mg | Oral |